Non-small cell lung cancer
This article was originally published in The Gray Sheet
Integrated PET and CT improves diagnostic capability of staging non-small cell lung cancer, according to a study in the June 19 New England Journal of Medicine. Using GE Medical System's Discovery LS integrated PET-CT, the investigators prospectively evaluated 50 patients with proven NSC compared with CT and PET alone and visually correlated PT and CT images. Discovery LS provided additional information in 20 of 49 patients (41%) beyond conventional visual correlation of PET and CT...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.